A Global Innovation in Regenerative Medicine

Maintain your physical edge without the strain. BIXEPS is an award-winning, patented medical technology born from a prestigious, multi-year research collaboration between the National University of Singapore (NUS) and ETH Zurich—Switzerland’s premier STEM university.

What is BIXEPS?

Utilising precision Pulsed Electromagnetic Field (PEMF) technology, BIXEPS safely stimulates the benefits of high-intensity exercise at a cellular level. It stands as a revolutionary, non-invasive solution engineered to activate mitochondria and condition muscle fibres completely bypassing the need for physical exertion, perspiration, or joint impact.

The Science of Magnetic Mitohormesis

BIXEPS re-engineers human health from the inside out by targeting the very foundations of cellular metabolism:

• Mitochondrial Jumpstart (ATP Production): BIXEPS targets the “powerhouses” of your cells to significantly increase Adenosine Triphosphate (ATP) production. This surge in cellular energy accelerates natural tissue repair while actively slowing cellular senescence (the accumulation of damaged “zombie” cells).

• Myokine Signalling (The Healing Cascade): Upon activation, your skeletal muscles release Myokines—beneficial proteins that travel through the bloodstream to suppress systemic inflammation, boost cognitive function, and enhance insulin sensitivity.

• Mitophagy & Cellular Renewal: The targeted magnetic resonance promotes metabolic clearing (the removal of dysfunctional mitochondria) alongside mitochondrial biogenesis (the creation of pristine, healthy mitochondria), leading to systemic tissue regeneration and superior immune regulation.

Clinically Proven Results: Data That Matters

Robust clinical trials involving participants aged 38 to 91 have validated BIXEPS as a definitive breakthrough in reversing age-related deconditioning, optimising body composition, and managing chronic musculoskeletal pain.

1. Advanced Pain Management & Recovery

• Systemic Relief: A remarkable 62.6% average reduction in general body pain scores.

• Lower Limb Targeted Relief: An average 33.3% reduction in localised lower limb discomfort.

• Severe Pain Alleviation: Patients presenting with high baseline pain experienced a significant, measurable drop of 2.12 points on the Visual Analogue Scale (VAS).

2. Metabolic Optimisation & Body Composition (8-Week Protocol)

• Visceral Fat Reduction: A 3.7% decrease in dangerous visceral (internal) fat.

• Total Body Fat Loss: A 3.9% reduction in overall body fat percentage.

• Skeletal Muscle Growth: A 1.2% increase in lean skeletal muscle mass without weight-bearing strain.

3. Senior Vitality, Balance & Physical Autonomy

Preserving muscle mass and motor control is the ultimate insurance policy for longevity. BIXEPS provides a risk-free, clinical environment for seniors to safeguard their independence:

• 85% of seniors demonstrated a measurable increase in lower-limb strength.

• 84% of seniors showed documented improvements in postural balance.

• 74% of seniors reported enhanced overall mobility and fluid ease of movement.

• 10–15% improvement in objective gait speed and “Timed Up and Go” (TUG) clinical scores.